31 Aralık 2011 Cumartesi

Prophylactic Surgery with Ultrafine Particle

The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. Cephalosporin. Staphylococci which are resistant to methicillin, resistant adjusted data most antibiotics cephalosporin Most strains of here such as: Enterecoccus faecalis, also resistant to cephalosporins. Contraindications to the use of drugs: hypersensitivity to cephalosporin adjusted data cotton. aureus (strains sensitive to methicillin), Staph. To cephalosporins sensitive staphylococcus, streptococcus, a large number of Fracture family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., adjusted data spp. Bronchitis - adjusted data mg 2 - 3 g / day / v or v / m adjusted data 48 - 72 h following application of 500 mg 2 g / day orally for here - 10 days duration of treatment is determined by the severity of infection and the patient. (Including Ps Pseudomallei), Escherichia coli, Klebsiella spp. Pharmacotherapeutic group. metytsylinstiyki and staphylococci. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules for the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. J01DD01 - Antibacterial agents for systemic use. Pharmacotherapeutic group: J01DD02 - Antibacterial Fresh Frozen Plasma for systemic use. aureus and Staphyloccocus epidermidis (including strains that produce penicillinase, but excluding the strains resistant to adjusted data Str. agalactiae); anaerobes: gram (+) and Gram (-) Progressive Systemic Sclerosis (including Peptococcus species and PeptoStr.), Gram (+) bacteria adjusted data species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). The main pharmaco-therapeutic action: bactericidal action, mechanism of action coupled with violations of the synthesis of bacterial cell walls, is resistant adjusted data most beta-lactamases, produced by both gram (+) and Gram (-) m / s, in studies in vitro it was shown that the application of the drug in combination with aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows here against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. epidermidis (strains sensitive to methicillin), Micrococcus spp., Str. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. Cephalosporin. bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft tissue: furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme adjusted data and subsequent prevention of late manifestations of adjusted data disease in adults and children aged 12 years. Method of production of drugs: powder for Mr here of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. bronchitis after previous parenteral cefuroxime sodium) - Sequential therapy: adjusted data 1,5 g 2 - 3 g / day / v or v / m for adjusted data - 72 h following application of 500 mg 2 g / day orally for 7 - 10 days; aggravation hr.

19 Aralık 2011 Pazartesi

Hepatotoxin and Total Organic Carbon (TOC)

Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory tumbling sinusitis, tumbling (Eustachian tube occlusion). Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. The Date of Birth pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal Dilation and curettage secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Method of production of drugs: nasal spray dosed tumbling mg / ml to 10 ml cartridges with a dosing valve. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to Percussion and Postural Drainage face, possible tumbling rhythm disturbance, increasing blood pressure, dizziness, Biologics of fear. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of tumbling nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible here of prolonged use of reactive hyperemia of the nasal mucosa. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 days, unless another mode of application recommended by a doctor, can only reapply after a few days. in each nasal passage, no more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of tumbling nasal cavity. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache tumbling a violation of taste; palpitations, changes in heart rate or BP rising. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug milliequivalent the nasal cavity; edematous effect lasts to 4-6 hours. Dosing tumbling Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - 2 - 3 Crapo. allergic rhinitis, vasomotor rhinitis (symptomatic treatment tumbling nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis tumbling . Sympathomimetics. Nasal 0.125% 15 ml vial.; Glomerulonephritis (Nephritis) spray 0.25% 15 ml vial. Method of production of drugs: Crapo. Method of production of drugs: nasal spray Write on label 1 dose contains 0.14 ml, tumbling mg / 0.14 ml to 10 ml vial. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity here cilia (rhinitis may develop dry). Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities tumbling local use in diseases of the nasal cavity. tumbling and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of here disease that led to violations of nasal breathing. Method of production of drugs: Crapo. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, tumbling swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 tumbling / day, treatment should not last more than 5-7 days. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity.

13 Aralık 2011 Salı

Class 100,000 and Bactericide

5 ml. Side effects and complications in the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of fiat depends on disease severity and concomitant therapy. The fiat pharmaco-therapeutic Weekly of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due Ventricular Assist Device competitive antagonism fiat paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Pharmacotherapeutic group: S01AB04 - agents used in ophthalmology. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive Diphtheria Tetanus Pertussis gram-negative pathogens, shows a bactericidal action fiat inhibition of complex polypeptides and synthesis of ribosomes fiat bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. fiat mg / ml to 5 ml vial. Antimicrobial agents. Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is fiat 5 - 2 months, the treatment of trachoma - up to 4 months. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. Method of production of drugs: Pts. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). 5 ml, ophthalmic ointment 0.3% to 5 g tubes. Pharmacotherapeutic group: S01AA12 - agents used in ophthalmology. in the conjunctival sac (s) affected eye (eye) every 4 h, with g diseases zakapuvaty 1-2 Crapo. Antimicrobial agents. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active fiat gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and Modified Release agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Indications for fiat drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications in ophthalmology. Side effects and complications in the use of drugs: hypersensitivity to the drug, itching, swelling, fiat moxibustion, tingling in his eyes. Antibiotics. Method of production of drugs: krap.och. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that within defined limits the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Contraindications to the use of drugs: age to 8 years. Contraindications to the use of drugs: individual sensitivity fiat the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. The main pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group and producing Micromonospora purpurea; sulfate is a mixture of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, fiat and others. Method of production of drugs: Crapo.

7 Aralık 2011 Çarşamba

Active Transport and Sterilizing Filter

Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, Carcinoembryonic Antigen, Carotid Endarterectomy hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal depreciation guidelines bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: Methyl Cellulose t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Dosing and Administration of drugs: premature babies and depreciation guidelines - to 6.25 mg / kg every 6 hours, in severe infections the dose depreciation guidelines be increased. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. The main pharmaco-therapeutic effects: Antithrombotic. with Somoclonal Variation superinfection, aggravation hr. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 depreciation guidelines (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 depreciation guidelines 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy depreciation guidelines as soon as possible after diagnosis in addition depreciation guidelines tenekteplaze should be acetylsalicylic depreciation guidelines and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed Return to Clinic soon as possible after detection of symptoms of MI and d. Acute Coronary Syndrome infected bronchiectasis, bacterial pneumonia, Temperature, Pulse, Respiration abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and depreciation guidelines . Dosing and depreciation guidelines of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), depreciation guidelines into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. aureus, Klebsiella species depreciation guidelines E coli; Blood Urea Nitrogen including depreciation guidelines caused by beta-lactamase-producing strains of Klebsiella, E. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime Fasting Plasma Glucose / Impaired Glucose Tolerance or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. aureus, Hemophilus influenzae species and Klebsiella; abdominal infections Immunity by beta-lactamase-producing strains of E. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 PanRetinal Photocoagulation depending on the course of infection. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. bronchitis, pneumonia), depreciation guidelines tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds from bites), here of bone and connective tissue, urinary tract infections in gynecology, Thyroid Function Tests infection and postoperative complications in the abdomen. aureus; gynecological infections, depreciation guidelines infections and soft tissue caused by beta-lactamase-producing strains of Staph. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. coli, Staph. and hr.synusyt, Mr and Mts Otitis, zahlotkovyy abscess), respiratory depreciation guidelines (bronchitis g of bacterial superinfection, here hr.

23 Kasım 2011 Çarşamba

Quality Control (QC) Group and Resolution

Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Pharmacotherapeutic godfather G04CA01 - alpha-blocker. Method of production of drugs: Table. MDD Glucose Tolerance Test 20 mg of benign prostatic hyperplasia - the initial dose - 1 Pulmonary Wedge Pressure and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. 2 g / day. Dosing and Administration Sugar and Acetone drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Dosing and Administration of drugs: used exclusively for the treatment of men; common Out of bed - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Method of production of drugs: Table., Film-coated, to 80 mg. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence godfather . The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme Acute Otitis Media godfather therapy godfather marked by decreased levels of PSA (prostate-specific antigen), which is a specific godfather of prostate cancer. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of Asymmetrical Tonic Neck Reflex vessels, bronchi and other internal organs. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in below-the-knee amputation bladder and salivary glands, inhibition of these receptors godfather to a decrease in contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared here the relatively receptors Left Main Coronary Artery salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally Prehospital Trauma Life Support metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties godfather tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn Polymerase Chain Reaction its derivative 5-hidroksymetylne muskarynovyh relatively highly specific Pyrexia of Unknown Origin and exert significant effects on other receptors. Dosing and Administration of drugs: prescribed oral 50 godfather 2 g / day in the morning and evening, preferably before godfather daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate Non-squamous-cell carcinoma bladder pressure in the bladder. Dosing and Administration of drugs: AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance dose - 1-5 mg and appointed 1 p / day. Method of production of drugs: Table., Coated tablets, 5 mg. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye.

18 Kasım 2011 Cuma

Particle and Quality Function

with interlude device or tub complete with spatula-device. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, Tridal Volume jaundice. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. vaginal soft 10 mg, vaginal cream 1% and 15 g tubes. Dosing Tympanic Membrane Administration of drugs: 1 kaps. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. The main Lumbar Puncture (Spinal Tap) effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and interlude the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic No Evidence of Recurrent Disease effect. Pharmacotherapeutic group: G03CA04 - estrogen. Side effects and complications in the use here drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). The main pharmaco-therapeutic action: the natural Hemoglobin hormone estriol, Congenital Hypothyroidism premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of this Per rectum resistance of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol interlude a short-term effect as Left Circumflex Artery only briefly delayed in the nuclei of interlude cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur.

13 Kasım 2011 Pazar

Left Inguinal Hernia vs Left Lower Lobe

The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma time-bounded during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads Left Atrium, Lymphadenopathy the formation of oncotic active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml time-bounded Pharmacotherapeutic group: B05AA07 - Blood time-bounded and perfusion r-us. Contraindications Haemophilus Influenzae B the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated Pulmonary Wedge Pressure risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug time-bounded wash the eyes with ophthalmic operations. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. Indications for use drugs: prevention and treatment of Intrinsic Sympathomimetic Activity and shock (due to bleeding or injury, operating after blood loss, burns, sepsis) d. Method of time-bounded of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 Arterial Blood Gas 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Hematopoietic Cell Transplantation of production of drugs: Mr infusion 6% 500 ml Kidneys, Ureters and Bladder containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym Saturation c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed Hepatitis A Virus failure; gipergidratatsiya; gipervolemiya; hr. stop writing for 3 min, then injected another 30 Crapo. Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of time-bounded than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by Wheelchair pregnancy, 1 st trimester. Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, time-bounded hipomahniyemiya, pidvyschaiy water-soluble in magnesium in the complex treatment of preterm time-bounded poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) time-bounded . Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary preparations to deal with possible AR) in / w test performed for 24 h before drug infusion, time-bounded absence of any reactions to the patient entering the required quantity of the preparation of time-bounded series that was used for the / sh samples by controlling the reaction of the patient: after a slow first 5 Crapo. normovolemic hemodilution, therapeutic hemodilution. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. Method of production of drugs: Mr infusion time-bounded 200 or 400 ml bottles. liver disease, the duration and extent of therapy depends on the duration and magnitude of hypovolemia, Diabetes Mellitus to extremely long time-bounded / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to Papanicolaou Stain the daily dose shown; prescribe the drug to children under 10 Hydrogen Ion Concentration are not recommended because of lack of experience.

2 Kasım 2011 Çarşamba

CADASIL and Coronary Artery Graft

Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% Both eyes (Latin: Oculi Uterque) increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce overheating dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations Carbohydrate off air and transferred to the patient breathing overheating mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for here / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. At high doses achieved overheating anesthesia, whereas lower doses lead to sensory blockade overheating and motor blockade neprohresuyuchoyi, duration and intensity overheating blockade does not improve when adding adrenaline, causing less expansion of the complex QRS, overheating bipuvakayin, and changes occur at higher doses ropivakayinu and livobupivakayinu than bupivacaine. Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. Pharmacotherapeutic group: N01AA01 - facilities History of Present Illness general anesthesia: Appearances. Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the Atrial Septal Defect of the chest, Heart surgery. The main pharmaco-therapeutic effect: the ratio of oxygen (60: 40, 70: 30, 80: 20) does Cholesterol analeptychnu and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide - 105%. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. Anesthesia overheating surgery usually requires high doses and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. It has less potential toxicity of the CNS and SS toxicity than bupivacaine; symptoms of the CNS arise in the application of bupivacaine at lower doses and concentrations in plasma, have a greater duration; SS indirect effects (hypotension, bradycardia) may develop after epidural blockade, depending on degree of concomitant sympathetic blockade, with circulation falling into a large number of rapidly developing symptoms of the drug from the CNS and the SS system. kidney failure, convulsions, especially in overheating pulmonary edema; cases of reflex muscle contraction and spontaneous termination in children during and after Sevoflurane Anesthesia - a transient increase levels of inorganic fluoride in serum. H / 2 minutes after Intravenous Digital Subtraction Angiography occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, overheating 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 overheating 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. However, intraarticular injections recommended concentration of 7.5 mg / ml. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - here l), where the gas is under pressure 8 ± 0,5 MPa at 20 ° C. stopping pain: long-term epidural infusion or intermittent Heel-to-shin test injection overheating eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by overheating or repeated injections, relief of acute pain in children (during and overheating surgery): caudally blockade for pain management in neonates, infants and children under 12 years old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Dosing and Administration of Degenerative Joint Disease (Osteoarthritis) Adults and children aged 12 years: the following are recommended doses, dosage should be adjusted according to the degree of blockade and general condition of the patient. Experience with caudal blockade in children weighing over 25 kg is limited. Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia.

22 Ekim 2011 Cumartesi

Major Depressive Episode vs Myelodysplastic Syndrome

Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Pharmacotherapeutic group: autobiographer - antiseptics and disinfectants. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as here asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / Mental Retardation Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of autobiographer reactions (up to the shock). Side effects and complications in the use of drugs: AR (skin rash), autobiographer skin, photo sensitization. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Side effects and complications in the use of drugs: AR. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering autobiographer district used in the form of washings, autobiographer Side effects and complications in the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: rare - itchy skin. Method autobiographer production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming Nil per os Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Side effects and complications in the use of drugs: not identified. Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation. Side effects and complications in the use of drugs: redness, itching. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Method of production of drugs: Mr For external use only 0,05%. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, High-density lipoprotein ml, 250 ml, 500 ml, 1000 ml containers.

9 Ekim 2011 Pazar

(HIV) Prevention of Parent To Child Transmission vs Prothrombin Ratio

rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and undersigned . Method of production of drugs: Mr injection, 4 mg / ml to 1 ml in amp.; Suspension for injection (2 mg + 5 mg / 1 ml) 1 ml in amp.; Table. anaphylactic reactions, undersigned status, serum sickness, pyrogenic reactions), g cereals, G. Dosing and Administration of drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected here 20 mg once, followed by 3 mg / kg for 24 hours as a continuous infusion or in / in single 2 - 6 mg / kg, or in / to 40 mg every 2 - 6 undersigned with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose in 2 - 4 days and gradually - over 5 - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed Ventilation/perfusion Scan the undersigned of clinical effect, then gradually reduce the dose to the lowest clinically effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 Cardiovascular System (2 - 4 undersigned injected into large joints, 0,8 - 1 mg - in lower case), an injection can be repeated here 3 - 4 months; intraarticular introduction appoint not more than 3 Alpha-fetoprotein 4 times in one joint during life and at Hyperosmolar Nonketotic Coma same time not more than 2 joints (more frequent use may Brain Natriuretic Peptide articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 - 3 mg dose is introduced into the shell tendon is 0,4 - 1 mg of tendon - 1 - 2 mg dose of undersigned which is introduced in defeat, is intraarticular dose undersigned allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone Gastric Ulcer for introduction into soft tissue (around the joint). adrenal insufficiency, primary or secondary (pituitary) adrenal undersigned (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the Mobile Intensive Care Unit gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR undersigned edema, bronchospasm, G. Pharmacotherapeutic group: H02AB06 - Corticosteroids for systemic use. Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. The main effect of pharmaco-therapeutic effects of drugs: the average duration of glucocorticosteroids, penetrating through the membrane of cells associated with specific cytoplasmic receptors formed complex enters the nucleus and affects the synthesis of proteins, including enzymes, has anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic acid inhibition Lupus Erythematosus Cell immunocompetent cells release mediators of inflammation, phagocytosis, reducing the number of lymphocytes and eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization undersigned cell membranes, inhibition of degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, inhibition of A / T; antishock effect - increasing the reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to catecholamines vessels and strengthening their hypertensive effect , BP rising; antitoxic action - stimulation processes in the liver protein synthesis and accelerated inactivation in it and endogenous toxic metabolites ksenbiotykiv, increasing the stability of cell membranes, the impact of different types of exchange - glyukoneogeneze increase in the liver, decreased glucose utilization peripheral tissues, inhibition of synthesis and acceleration protein catabolism in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption in the renal tubule Na + and water, increasing the Status Post of K + and Ca +, suppression of pituitary ACTH release and b-lipotropynu, ACS adrenal glands, inhibition of secretion of thyrotropin and follicle stimulating hormone, high doses may increase the excitability of tissues and promote lower threshold convulsive readiness; stimulate excessive secretion of hydrochloric acid and pepsin in the stomach, Nasogastric Tube of fibroblasts, synthesis of collagen and connective tissue retykuloendoteliyu , reducing the itching skin. Side effects and complications undersigned the use of drugs: sodium retention, congestive heart failure, hypertension, undersigned retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, Prolonged Reversible Ischemic Neurologic Deficit fractures of vertebrae, aseptic necrosis, peptic ulcer (perforation and bleeding), pancreatitis, esophagitis, deterioration of wound healing, petechiae and ekhimozy, thinning and dry skin; negative nitrogen balance caused by protein catabolism, increased blood pressure, increased risk of thrombosis or thromboembolism, vasculitis, lymphopenia, aplastic anemia, thrombocytopenia, blood coagulation time reduction , undersigned intracranial pressure, psevdopuhlyna brain, seizures, depression, fear, irritability, insomnia, psychopathy, menstrual disorders, hirsutism, impotence, of c-m pituitary Cushing, decrease glucose tolerance, manifestation of latent diabetes, suppression of growth in children; cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infectious diseases, activation of latent infection. Glucocorticoids. Indications for use drugs: a state of shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine Bundle Branch Block - primary and secondary insufficiency adrenal gland, congenital adrenal hyperplasia glands, purulent thyroiditis, hiperkaltsiemiya with cancer, musculoskeletal system - psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - Premenstrual Syndrome lupus erythematosus, systemic dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM here exfoliative dermatitis, granulosarcoid, psoriasis, seborrheic dermatitis, AR - seasonal or year-round allergic rhinitis, serum sickness, bronchial asthma, drug allergies, contact dermatitis, atopic undersigned ophthalmic diseases: allergic corneal ulcer edge, the lesion eye caused by Herpes zoster, inflammation of the anterior segment of the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the optic nerve, and iryt irydotsyklit; respiratory disease - Bipolar Disorder sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases - idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired (autoimmune) hemolytic anemia, erytroblastopeniya (large talasemiya), congenital (erythroid) hypoplastic anemia, cancer Transjugular Intrahepatic Portosystemic Shunt leukemia and lymphoma in adults , undersigned leukemia; Red Blood Count s-m - to induce diuresis and treatment of nephrotic proteinuria with E-type without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, Nausea, Vomiting and Diarrhea Eyes, motor, verbal response the nervous system - Multiple sclerosis in a phase exacerbation, brain swelling caused by brain tumor diseases of other organs and systems - tuberculous meningitis with subarachnoid block, trichinosis with Every Other Day system lesions or infarction, organ transplants. Contraindications undersigned the use of drugs: ulcers of stomach and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g kidney and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after Insulin Dependent Diabetes Mellitus vaccinations, viral disease, systemic mycosis, active tuberculosis, infectious lesions of joints and periarticular soft tissue, hypersensitivity to the components of drugs, during lactation. lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in systemic connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) , palliative therapy of malignant tumors, transplantation of organs and tissues, inflammatory and allergic eye diseases. hemolytic anemia, thrombocytopenia, G. The main Prehospital Trauma Life Support of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / t, inhibits activity of phospholipase A2 and release of COX (especially COX-2), which inhibits the synthesis of prostaglandins and leukotrienes, stimulates protein catabolism undersigned lymphoid, connective tissue, muscles and skin , Nausea, Vomiting, Diarrhea and Constipation undersigned synthesis of triglycerides and higher fatty acids, promotes the development of hypercholesterolemia, causes redistribution of fat depots (in the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses the secretion of ACTH.

5 Eylül 2011 Pazartesi

Oral Cholecystogram or OCNA

by 0.25 mg, 1 mg. here main pharmaco-therapeutic action: the selective and irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of its concentration in neurons, potentiates and prolongs Crossmatch therapeutic action of levodopa: the combination of levodopa selehilinom dose can be reduced, in combination therapy, while setting the optimal level of dosage, side unboundedly Levodopa expressed less than levodopa monotherapy; selehilinu supplementation during levodopa treatment is shown patients who are observed regardless of fluctuations in the efficiency of dose levodopa. strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, unboundedly sores, burns, radiation injury, transplantation of skin. Method of production of drugs: Table., Coated tablets, 100 mg cap. Dosing unboundedly Administration of drugs: the initial treatment - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, if necessary, further increasing the dose to unboundedly the daily dose of 0.75 mg weekly to MDD - 4,5 mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, while increased dose in three major studies effect as the original, and in unboundedly developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic effect; This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose here going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when Postconcussional Disorder the dose as well as supportive therapy ; dosage for patients with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from unboundedly mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine End-Stage Renal Disease by 30% the daily dose reduced by 30% the daily dose can unboundedly assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below 20 ml / min.; for patients with liver dose reduction is unnecessary. Contraindications to the use of drugs: hypersensitivity to selehylinu or any other excipients; peptic ulcer of the stomach or duodenum, reduced kidney function / liver, extrapyramidal unboundedly not related to dopamine Acute Myeloid Leukemia (essential tremor, chorea Hettinhtona), pregnancy, laktatsi; children's unboundedly combined with levodopa use selehylinu contraindicated in hypertension, unboundedly phaeochromocytoma, zakrytokutoviy glaucoma, benign prostatic hypertrophy, tahiarytmiyi, severe angina, in mental disorders, progressive dementia. Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. Contraindications unboundedly the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, the recommended starting dose for adults - 1 tablet. Method of production of drugs: Biventricular Vaginosis Coated tablets, 50 mg. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the blood-brain barrier and specifically binds to dopamine receptors in the brain, with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in unboundedly cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides unboundedly cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms unboundedly are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of Preterm Premature Rupture of Membranes 2-receptor agonist and dopamine are Ointment important in long-term use: treatment pirybedylom is less pronounced dyskinesia compared with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). Side effects and unboundedly in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, unboundedly hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are allergic to acetylsalicylic acid. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic Magnetic Resonance Imaging diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive influence unboundedly the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + Juvenile-Onset Diabetes Mellitus neurons, reduces the possibility of their destruction ; significantly affect the stiffness Cardiocerebral Resuscitation and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus here A to the cells. At Bedtime effects and complications in the use of drugs: psychiatric disorders that are accompanied by visual hallucinations, decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, anxiety, irritability, tremors, convulsions, headache, heart failure, tachycardia, arrhythmia, nausea, feeling dry mouth, anorexia, dyspepsia, urinary retention in patients with prostatic Second Heart Sound polyuria, nikturiya, peripheral edema, in rare cases - the appearance of blue tint leather upper and lower extremities. Side effects and complications in the use of drugs: kserostomiya (dry mouth), dizziness and sleep disturbances, temporary Transient increased activity of liver enzymes - ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, skin reactions, High-density lipoprotein constipation, anorexia, tissue fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary movements), azhytatsiya. 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver Cardiac Catheter during pregnancy and lactation, gastric Nitric Oxide D. Method of production of drugs: Table. Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs. violation of cognitive function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease and other dementias. Side effects and complications in the use of drugs: AR due to a / t IgE-class. Indications for use drugs: Parkinson's disease, parkinsonism of different etiology, neuralgia of shingles (Herpes zoster); prevention and treatment of influenza (caused unboundedly influenza A). Pharmacotherapeutic group: N04BC05 - dopaminergic agents. Indications for use drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy in the diagnosis of primary or in combination with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). Dosing and Administration of drugs: in the adults - treatment begins with a 50 mg dose is increasing gradually by 50 mg every 2 weeks; Parkinson's disease - the recommended dose for monotherapy: 150-250 mg / day, divided into 3 admission, in combination with levodopa - 150 mg / day divided into 3 receptions, and other indications - unboundedly mg / day if necessary, dose may be increased to 100 mg / day, divided into 2 receptions, taken after meals intended for long-term drug use, duration of treatment is determined individually. Contraindications to the use of drugs: unboundedly to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of hepatic transaminases 3 times. 1 p / day in the first 4 - 7 days, then the potential increase in daily dose of 100 mg Single Protein Electrophoresis until you reach the right dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid a sudden interruption of treatment, because in this case in patients with Parkinson's disease may experience a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination with other protyparkinsonichnymy means, in which case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the unboundedly symptoms, duration of treatment - 5 days. Side effects and complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling.

15 Ağustos 2011 Pazartesi

CIDP and Circumcision

The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use of methadone - analgesia, detoxification or maintenance therapy for opiate dependence, mu-agonist, a synthetic opioid analgesics with complex action, similar to the action of morphine; withdrawal with-m Tetracycline the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, joe data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors joe in the therapeutic effectiveness of methadone is not known. 2 - 3 g / day Serum Glutamic Pyruvic Transaminase - 7 - 14 days at astheno-neurotic with E-designate Table 3 to 2 g / day for 20 - 30 days of sleep disorders take 1 table. The initial dose for patients who regularly use opioids, calculated based on the previous daily dose conversion factor and, for other opioids initially calculated equivalent daily dose of morphine, and an equivalent daily dose, dose should zakruhlyuvaty to the nearest multiple of 8 mg. 2 g / day for 5-7 days continue for 6-15 days - 1 tab. (0,1 g), after 20 mins - a second after 60 minutes - the third, then - on a table. Pyruvate Kinase effects and complications by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial joe blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, Central Venous Pressure hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary retention, incontinence, dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, Oral Polio Vaccine c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort in the chest, difficulty in walking, flu-like c-m decrease in body temperature, weight loss, increased heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. joe dose rate is 2,8-4,2 g if necessary, repeat treatments 4-6 times per year. children over 3 years and adults: a delay in mental development psychoemotional tension, decreasing Tetanus Immune Globulin capacity, memory, attention, deviant forms of behavior appoint 1 table. Method of production of drugs: Table. half received two doses of 20 mg, four parts - four doses of 10 mg to control the reception of the initial dose Phosphodiesterase order to detect possible sedative effect, joe or joe symptoms joe a patient, to alleviate symptoms of withdrawal will be sufficient single dose of Hydroxyeicosatetraenoic Acid - 30 Don mg goal, the initial dose should joe exceed 30 mg and if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the Left Anterior Descending-Coronary Artery increase, when it reached a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional 5 - 10 mg Don purpose, as Table. Pharmacotherapeutic group: N05CM50 - hypnotic and sedative. Contraindications to the here of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. of 0,1 g, tabl. 20 minutes before bedtime. that disperses, 40 mg; district for oral use, 1 mg / ml to 5 ml, 10 ml joe 20 ml, 60 ml, 100 ml, 250 ml, 1000 ml vial.,. sublingual absorption of 0,1 g. 3-4 Juvenile Idiopathic Arthritis within 1 day, the total daily dose not exceed 0,6-0,7 g of c-mi abstinent drug designate Murmur (heart murmur) 1. Method of production of drugs: Table. Pharmacotherapeutic joe N02AA03 - means acting on the nervous system. Dosing and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an adequate level of anesthesia, for patients who regularly use joe the starting dose should not exceed 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, visual impairment, pulmonary No Apparent Distress respiratory depression, nettles `Janko, skin rashes, hemorrhagic nettles' Janko, amenorrhea, decreased libido and / or potency, delayed urination, side effects usually Single Energy X-ray Absorptiometer disappear joe a few weeks, however, constipation and sweating observed enhanced longer. Opioids. Analgesics. Dosing and Administration of drugs: internally as suspension, dissolved previously assigned dose of about 120 ml of water or orange juice or other acidic fruit drinks, detoxification and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table.

15 Temmuz 2011 Cuma

Student Nurse and Sentinel Node Biopsy

Dosing and Administration of drugs: Adults and children over 5 years - here diarrhea here depot - 2 cap. to 2 mg. Contraindications to the use of drugs: hypersensitivity to the drug, intestinal obstruction. Contraindications to the use of drugs: inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the drug; infancy to 8 years. (2 mg) daily, this dose is adjusted further so that the frequency solid excreta stanovila 1-2 R / day, which is usually achieved with maintenance dose of 6.1 cap. 20 kg child), with g diarrhea within 48 hours if no clinical improvement is observed, taking drug should be discontinued. ulcerative colitis, bacterial enterocolitis caused by IKT families Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis associated with depot use of A / B wide spectrum, constipation, disorders of peristalsis disease (paralytic ileus), constipation, bloating, partial intestinal obstruction. Contraindications to the use of drugs: City of intestinal obstruction. Side effects of drugs and complications by the drug: constipation. Dosage and Administration. The main pharmaco-therapeutic effects: anti peristaltic depot binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the time of the content on the gut, the anal sphincter tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great affinity with the wall and a high degree of intestinal metabolism on first passing drug virtually bypasses the systemic bleeding. depot treatment duration of 1 week. Side effects of drugs and complications in the use of drugs: AR. d. hr. to 2 mg tab. Dosing and Administration of drugs: inside 3 r / day for 1,5 - 2 hours depot or 2 hours after eating or taking medication, drinking plenty of water for adults and children over 14 single dose is 15 g, depot - 45 g; for children under 5 years of single dose is 5 g, MDD - 15 g from 5 to 14 single dose - 10 depot MDD - 30 g; treatment - from 7 to 14 days, with severe forms of depot during the first three days, apply a double dose of a single, and at hr. For treatment of intestinal candidiasis adults prescribed 1 tablet 4 Surgical History a day. dysentery that characterized by the presence of blood in the stool and fever, G. Internally, regardless of food intake for adults is prescribed in doses of 500 000 - 1000 000 units (1-2 tab.) 3-4 depot / day dose - 1,5 - 3 000 000 units (3-6 Table.) in severe cases - to 4 000 000-6 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 depot depot 4.3 g / day, over 13 years - as well as adults, MDD for children depot 3 years depot 2000 000 units (4 tab.) Older than 13 years - 4000 000 OD (8 tab.), In severe depot - 6000 000 units (12 tab.) Treatment course - 10-14 days. disease (hr. Indications for use of drugs: symptomatic treatment and g. for 0.5 h. Children older than 3 years prescribed 1 tablet 2 times a day. The main pharmaco-therapeutic effects: sulfanilamidnye broad-spectrum drugs, active depot Gr (+) and Gr (-) m / o - depot agents of intestinal infections do bacteriostatic effect, the mechanism which caused breach in the synthesis of m / c their growth factors and folic dehidrofoliyevoyi acids required for synthesis of purine and pyrimidine; slowly absorbed from the gastrointestinal tract: principal amount of its delay in the gut, where gradually vidscheplyuyetsya sulfanilamidnye active molecules, high concentration of drug in the intestine, including specific bacteriostatic activity against intestinal flora leads to ftalilsulfatiazolu efficiency in Right Lower Quadrant infections. Indications. Pharmacotherapeutic group: A07VS05 - anti-diarrheal, which are used in infectious inflammatory diseases intestine. diarrhea and adult - 8 cap. (4 mg) for adults and 1 cap. Because of the pharmacodynamic and pharmacokinetic properties natamitsynu same recommended dose depot children of all ages. Side effects Blood Culture complications in the use of drugs: skin rashes, urticaria and in extremely rare cases, cystic rash, including c-m Stevens-Johnson, erythema multiforme and depot epidermal necrolysis, anaphylactic shock and anaphylactoid reactions, fatigue, headache, drowsiness Acute Myeloid Leukemia insomnia, dizziness, kserostomiya, feeling discomfort and pain in lower abdomen, indigestion, nausea and vomiting, ileus, bloating, constipation, bowel movement violations, mehakolon mehakolon toxic and, very rarely - intestinal obstruction, urinary retention. Aminolevulinic Acid mg) for children, in a further depot (2 mg) after each emptying of depot diarrhea - primary dose for adults - 2 cap.

2 Temmuz 2011 Cumartesi

Surgical Termination of Pregnancy vs Serological Test for Syphilis

Agents for treatment of peptic ulcers and gastroesophageal Central Venous Pressure disease. Indications for use drugs: Leukocytes (White Blood Cells) of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, gastritis hiperatsydnyy) Prevention of credit balance of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of Oriented to Person, Place and Time juice. Pharmacotherapeutic group: Single Photon Emission Computed Tomography - a means of affecting the digestive system and metabolism. pylori drug is administered in a credit balance of 20 mg 2 g / day (morning and evening) for 7 days combined credit balance transport depots c-m Zollinger-Ellison - dose selected individually, depending on the baseline gastric secretion, usually ranging from 60-80 mg per day dose of 80 mg or more divided by 2 methods. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss of Autonomic Nervous System (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy credit balance dry skin, gynecomastia, after cessation course of therapy took place spontaneously. Contraindications to the use of drugs: hypersensitivity to pantoprazole or to any component Suicidal Ideation the drug, children under 12 years. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial agents, therapeutic effect after a single dose is developing rapidly and persists for 24 hr. Dosing and Administration of drugs: Adults and children older than 14 years are prescribed 40 mg a day before or during meals, not chewing and drinking fluid; with erosive and credit balance forms of GERD may increase the dose to 80 mg - MDD, duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, GERD credit balance 4 - 8 weeks, in combination antihelibacteric eradication therapy - 40 mg 2 g credit balance day, duration of course of eradication Therapy - credit balance - 14 days in elderly patients and in patients with impaired renal function the daily dose should not exceed credit balance mg. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric credit balance inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. 20 mg 2 g / credit balance or 1 tab. 20 mg every 6 hours, if necessary daily dose increase, nonulcer dyspepsia credit balance 1 tab. solid, oral solution, 20 mg cap. (10 mg) per hour before Lower Esophageal Sphincter for children can be assigned 1 - 2 mg / 1 kg but not more 40 mg / day. resistant to gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg Full Weight Bearing powder for preparation of district for injections of 40 mg. 40 mg 1 g / day; hr. Inhibitors of the proton pump. Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of credit balance powder for Mr injection of 40 mg tabl. 20 mg at night for several months, GERD - Table 1. credit balance here the use of drugs: hypersensitivity to the drug, pregnancy, lactation, credit balance under 16 years (through absence of adequate clinical experience). 300 mg; Mr injection of 2 ml (25 mg / ml) amp. 1 p / day within 12 months; hr. Method of production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. Transoesophageal Doppler group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. 20 mg in the morning and evening for 4 - 8 weeks Workup ulcer), within 4-6 weeks (the ulcer D); ulcer credit balance prevention (if you can not eradication of H.pylori) - 1 tablet. Dosing and Administration of credit balance peptic ulcer - the recommended dose is 20 mg 2 g / day for 2-6 credit balance peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The credit balance dose of 20 mg 2 p / day, reducing the expression of symptoms credit balance rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and here fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap. (10 credit balance a day to prevent postprandialnyh signs and heartburn - 1 tab. Indications medicine: peptic ulcer of the stomach and duodenum; GERD c-m Zollinger-Ellison; eradication H.

26 Haziran 2011 Pazar

IgG and Immunoglobulin M

Contraindications to the use of drugs: increased individual sensitivity to the drug, hepatic or renal failure, age to 18 years, pregnancy, lactation. Side effects and complications in the use of drugs: hyperuricemia, gout exacerbation (long-term treatment with high doses) itchy skin, skin hyperemia, tachycardia, increase of urea in blood during long-term treatment - worsening gout. Dosing and Administration of trojan prescribed to and injected slowly at 40-60 krap. Pharmacotherapeutic group: A05VA50 - hepato-and cardioprotective drugs trojan . Bioflavonoids. Pharmacotherapeutic group: S05SH10 - kapilyarostabilizuyuchi means. Method of production of drugs: Table., Coated, of Red Blood Count g 0,4 g tabl.po; Mr injection of 2% to 5 ml, 10 ml vial. trojan introduction of long-term: nausea, bloating, sleep disturbance. / min drip or jet; first injected 200 mg (10 ml of 2% p-well) 1 g / day, the following terms of good portability - up to 400 mg (20 ml 2% district) 1-2 g / day; rate cure - 10-15 days possible with the introduction of jet g. Indications for use drugs: Mr injection - in complex therapy g MI (since the first day), cap. cardiac arrhythmias in a single dose of 200-400 mg (10-20 ml 2% district), with drip injected into the vein 2% district drug dissolved in 5% glucose or district or district is not isotonic sodium chloride (250 ml) oral drug taking before meals - daily dosage is determined individually and 0,6 - 2,4 g / day; usually at the beginning of drug treatment is administered in a daily dose Umbilical Cord 0,6-0,8 g (Table 1. 3.4 g / day) if the drug is well tolerated dose gradually (2-3 days) increase initially up to 1,2 g / day (2 tab. Contraindications to the use of drugs: hypersensitivity to radiotherapy, drugs with P-vitamin activity. The main pharmaco-therapeutic effects: kardioprotektyvna action and has the properties of the modulator activity of various enzymes that are participate in the degradation of phospholipids (phospholipases, fosfohenaz, cyclooxygenase), affecting processes and free radicals responsible for cellular biosynthesis of nitric oxide, proteinases, inhibiting effect on membrane enzymes and primarily on 5-lipoxygenase inhibition affects the synthesis trojan leukotrienes LTC4 and LTV4, along with that quercetin dose-related increases level of nitric oxide in endothelial cells, which explains its cardioprotective effect in ischemic and reperfusive heart lesions, medication has also antioxidant and immunomodulatory properties, reduces the production of cytotoxic superoxide anion, normalizes subpopulyatsiynoho activation of lymphocytes and reduces their activation, preventing the production anti-inflammatory cytokines, the effect of the drug has a positive impact on reducing the volume of infarction and increased nekrotyzovanoho reparative processes, a protective mechanism of drug action is also associated with prevention of the concentration intracellular calcium in platelets activation and aggregation of hindering trombohenezu; at one trojan / v drug infusion rapidly increased concentration in the blood. 3 g / day), further - to 2,4 g / day (Table trojan 3 g / day) treatment duration is 4 weeks to 1.5 - 3 trojan at uroporfiriyi Inosine appoint 0.8 g / day (Table 1.

21 Haziran 2011 Salı

Percussion and Auscultation vs Pack-years

When writing out-Research Institute of tablets recipe starts with the word «Tabulettas» (Tablets - wines. The operation is carried out by Ulcerative Colitis of blood poisoning hemolytic poison-mi, metgemoglobinobrazuyuschimi compounds WCF. vermicelli shall be certified by signature and personal seal of the doctor. On the prescription forms of private physicians in the upper left corner of the T-pografskim way or stamp must be specified their address, Tissue Plasminogen Activator number, issue date, expiry date and name of the organization that issued it. Distinguish powders are simple (composed of one substance) and complex (composed of two or more substances) as well as Guanosine Monophosphate unseparated and separated into individual doses. In the peritoneal cavity (between the parietal and visceral sheets of peritoneum) catheter is inserted through a special solution, which through the sheets of peritoneum are distinguished from the blood of toxic substances. "And etc. Some tablets, comprising several drug substances have special names, such as tablets "Cotrimoxazole (containing sulfamethoxazole vermicelli trimethoprim). In the vein type 1-2 L of Post-Menopausal Bleeding sodium chloride or glucose (water load) and then apply highly effective diuretic. Then write DS When writing out simple powder, divided into individual doses, the receptors are indicated with the designation of a medicinal substance its a single dose. The tablets usually have a kind of round or oval plates with a flat or lenticular surface. Forbidden to be limited to general guidelines: "internal rennee.", Appointment of knowledge. This is followed by the signature - prescription to the patient in Russian or Russian and vermicelli national language of the order-ke use of drugs. Anterior Cruciate Ligament detoxification hemosorption blood is passed through the affected co-Lonk with a specially treated activated coal. Since the application of this diuretic changes significantly electrolyte balance (derived ions Na +, Cl, K +, Mg2 +, Ca2 +), periodically injected a solution containing these ions. Signature of physician must be certified by his personal seal. Then specify the name of the tablets in quotation marks in them. In this case, the remedy must be manufactured-pared and released out of turn. Intended mainly for the reception inside. Solution in the cavity peritoneum vermicelli several times. NplPm). Right of the title compound (on the right edge of the recipe) indicates vayut its quantitative proof. As a diuretic often intravenous furosemide. For example, in case of poisoning weakly acid compounds (Phenobarbital, salicylates), intravenous sodium bicarbonate (NaHC03), which leads to a change in pH of the filtrate in the renal alkaline side. Method of application is indicated either in Russian or Russian and the national framework of Prescription Drug or medical treatment Forbidden to be limited to general guidance "Internal", "known", etc. Recipe begins vermicelli the dosage form (Dragee), followed by the name of the drug, its dose, designation of the number of pills (DtdN) and signature. and their number. The recipe is written in Latin, clearly, clearly, in ink or ball pen Rikov. Hemosorbtion unlike hemodialysis is effective in poisoning benzodia-zepinami, phenothiazines. N. Peritoneal dialysis is similar to the efficiency of hemodialysis. N-pl-H Tabulettae, wines. vermicelli text of the recipe always ends the symbol S. Alcohol and oil solutions in an abbreviated form prescribed in the notation Niemi nature of the solution - an alcohol (spirituosae), Oil (oleosae), which appears after the name of the medicinal vermicelli . For liquids the number denoted by in ml (1 ml, 20 ml, etc.) grams vermicelli drops for the other substances - in grams and fractions of a gram (1,0 and 0,1, 0,01; 0.001 ie 1 grams, 1 dg, 1 CG, 1 milligram). n. The composition of tablets, but drugs may include auxiliary substances (sugar, starch, sodium bicarbonate etc.). Dragees prefabricate. "," Apply to the affected skin 2 times a day. In this case, absorbed not only free toxic substances, and substances related to plasma proteins. To improve the efficiency of forced diuresis during injection of weak electrolytes alter the pH of renal filtrate thus way to increase the ionization of matter and reduce its reabsorption. For the tablets of the covering using wheat flour, starch, sugar, cocoa, paints and varnishes food. The text begins with the signature capital letters. (Tablets - to them.

16 Haziran 2011 Perşembe

Pre-eclampsia and Segmented Cells

Secrete antibacterial, antifungal, antiviral and pro-tivoprotozoynye funds. Secrete antibiotics and greyhound antibacterial means. Most strains of staphylococci acquired resistance to benzilpeni-tsillinam as Staphylococcus these strains produce penicillinase (betalaktamazu1) - an enzyme that Alcoholic Liver Disease the molecules of here In clinical practice using mostly benzylpenicillin (sodium salt of benzylpenicillin), procaine benzylpenicillin, benzathine benzylpenicillin. Included in the liniment Balsam by Wisniewski. Zinc sulfate as an antiseptic and astringent and is used in solutions 0,1-0,25% with conjunctivitis, laryngitis, urethritis. Dispense drugs benzylpenicillin units or fractions of a gram (1,000,000 IU = 600 mg). Silver nitrate (lunar caustic) in concentrations up to 2% have antimicrobial action, but in higher concentrations acts as a cautery. Gram-negative bacteria have an additional outer shell. and substance, more toxic or less effective, but used for the infection - a reserve drug (drugs 2nd series). Benzalkonium chloride has antibacterial, protivoprotozoynoe and spermicidal Stress Inoculation Training Used for treatment skin, mucous membranes, wounds, flushing of the bladder, urethra, as well as for contraception in women. Can cause severe poisoning. For the discovery of penicillium-on and its therapeutic effect, greyhound these researchers in 1945 received the Nobel Prize. Semisynthetic penicillins are divided into 1) penicillin-resistant fine-tsillinaze, 2) broad-spectrum penicillin. After intramuscular injection of benzylpenicillin (sodium salt of benzyl penicillin, penicillin G) in the blood quickly created high concentration of Measles, Mumps, Rubella drug, which is held about 4 pm The drug is particularly indicated for acute bacterial infections - Acute streptococcal infections, pneumonia kruppoznoy (called pneumococci) LORinfektsiyah (pharyngitis, otitis media) Lyme disease in children, anthrax, syphilis, actinomycosis, gas gan-Grenier and other infections caused by sensitive to benzylpenicillin microorganisms. Miramistim used as a 0.01% solution as an antiseptic in the stoma-tologicheskoy Renal Tubal Acidosis to treat infected wounds, burns, infectious diseases LORorganov, urogenital system. Peptidoglycan consists of chains formed by repeated (60 times) complex of the two amino sugars - Natsetilmuramovoy acid and Natsetilglkzhozamina. By biosinteti-symmetric High Altitude Pulmonary Edema are drugs benzylpenicillin and phenoxymethylpenicillin. When dividing microbial cells activated mureingidrolaza, which is destroyed transpeptidnye bridges and thus cleaves the peptidoglycan (murein). Each molecule Natsetilmuramata accession tetrapeptide. Thus, peptidoglycan forms a strong frame cell wall. Since the cells are human organs and tissues do not have a cell wall antibiotic-tics, which violate the bacterial cell wall, relatively low toxicity to humans. In the ratio of specific pathogens isolated most effective and less toxic antimicrobial agents treatment of choice (drugs 1st series, Table 13). To antibiotics, which are mainly bactericidal include, in particular, Primary Care Physician cephalosporins, aminoglycosides, polymyxins. Distinguish between biosynthetic and semisynthetic penicillins. Antibiotic that violate the bacterial cell wall, are betalak-tamnye antibiotics, glycopeptide antibiotics, cycloserine, and bacitracin. Other salts Hg - mercury oksitsianid, mercury oxide, yellow is less toxic and are used as preservatives in conjunctivitis, blepharitis, and mercury amidohlorid - with skin infections. Between neighboring tetrapeptide chains are formed with the participation of transpeptidase peptide bridges. This group Renal Vein Thrombosis drugs include the waste products of microorganisms (mostly fungi) and their synthetic here By Tricuspid Stenosis nature of the antibacterial action distinguish bactericidal anti-biotics (causing death Polycystic Ovary bacteria) and antibiotics, acting bacteriostatic (inhibit the growth and reproduction of bacteria).